20/20 Biolabs, Inc. (AIDX)
0.792
-0.05
(-5.99%)
USD |
NASDAQ |
Jun 09, 16:00
0.7975
+0.01
(+0.69%)
After-Hours: 20:00
20/20 Biolabs SG&A Expense (Quarterly) : 1.353M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 21.88M |
| Intelligent Bio Solutions, Inc. | 2.459M |
| Anteris Technologies Global Corp. | 6.93M |
| FONAR Corp. | 8.373M |
| Quest Diagnostics, Inc. | 504.00M |